加替沙星与左氧氟沙星口服治疗急性细菌性感染的药物经济学评价

目的评价口服加替沙星与左氧氟沙星治疗急性细菌性感染的成本-效果。方法查阅文献,选择分别口服加替沙星(A组)与左氧氟沙星(B组)治疗急性细菌性感染病例224例,运用药物经济学最小成本分析法、成果-效果分析法进行分析和评价。结果A、B组临床总有效率分别为95.6%、91.8%;治愈每例患者所需药品的最小成本分别为(287.1±95.7)元、(109.5±36.5)元;以临床总有效率计,成本-效果比分别为(14.67±2.13)、(13.58±1.65);A组相对于B组的增量成本-效果比为41。结论与加替沙星比较,左氧氟沙星治疗急性细菌性感染更具成本-效果优势。

Treating Acute Bacterial Infections with Oral Gatifloxacin and Levofloxacin: Evaluation on Pharmacoeconomic

OBJECTIVE:To evaluate the cost-effectiveness of oral gatifloxacin and levofloxacin in the treatment of acute bacterial infections.METHODS:224cases with acute bacterial infections treated with oral gatifloxacin(group A)and levofloxacin(group B)were collected respectively by reviewing literature,the analysis and evaluation was performed by cost-minimization analysis and cost-effectiveness analysis in pharmacoeconomics.RESULTS:Total effective rates of group A and B were95.6%and91.8%,respectively;Minimum costs for each case were(287.1±95.7)and(109.5±36.5)yuan,respectively;Calculated from the perspective of total effective rates,the cost-effectiveness ratios were(14.67±2.13)and(13.58±1.65),respectively;The incremental cost-effectiveness ratio of group A as against group B was41.CONCLUSION:Levofloxacin is of better cost-effectiveness advantage than gatifloxacin in the treatment of acute bacterial infections.